tiprankstipranks
Promore Pharma AB (DE:8T00)
STUTTGART:8T00
Germany Market
8T00
Promore Pharma AB
RESEARCH TOOLSreports

Promore Pharma AB (8T00) Financial Statements

0 Followers

Promore Pharma AB Financial Overview

Promore Pharma AB's market cap is currently €1.54M. The company's EPS TTM is €; its P/E ratio is ―; Promore Pharma AB is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ -14.89M$ -18.19M$ -16.37M$ -22.01M$ -10.31M
Operating Income$ -26.69M$ -29.09M$ -29.07M$ -32.68M$ -9.58M
EBITDA$ -26.60M$ -28.49M$ -27.55M$ -31.21M$ -6.79M
Net Income$ -26.77M$ -29.41M$ -28.86M$ -32.48M$ -8.43M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 47.20M$ 26.22M$ 68.73M$ 37.60M$ 71.35M
Total Debt$ 714.00K$ 714.00K$ 714.00K$ 714.04K$ 714.04K
Net Debt$ -44.60M$ -23.54M$ -59.83M$ -30.17M$ -62.26M
Total Liabilities$ 6.59M$ 3.43M$ 16.54M$ 4.35M$ 5.62M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -24.83M$ -37.48M$ -18.45M$ -32.52M$ -6.96M
Operating Cash Flow$ -24.83M$ -37.48M$ -18.45M$ -32.52M$ -6.96M
Investing Cash Flow
Financing Cash Flow

Promore Pharma AB Earnings and Revenue History

Income Statement >

Promore Pharma AB Debt to Assets

Balance Sheet >

Promore Pharma AB Cash Flow

Cash Flow >

Promore Pharma AB Forecast EPS vs Actual EPS

Earnings >